| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/27/2000 | WO2000043539A2 Immobilization of molecules on surfaces via polymer brushes |
| 07/27/2000 | WO2000043534A1 Method and apparatus for the automated generation of nucleic acid ligands |
| 07/27/2000 | WO2000043530A2 Stabilisation of compositions comprising non-viral nucleic acid transfer compositions |
| 07/27/2000 | WO2000043529A1 Method of increasing the water soluble antioxidant content in mechanically harvested peas |
| 07/27/2000 | WO2000043526A1 Mammalian serine racemase |
| 07/27/2000 | WO2000043525A2 Metalloproteinase-disintegrin family members: svph dnas and polypeptides |
| 07/27/2000 | WO2000043524A1 Polypeptides derived from jnk3 |
| 07/27/2000 | WO2000043523A2 Transgenic systems for the manufacture of poly(3-hydroxy -butyrate -co -3- hydroxyhexanoate) |
| 07/27/2000 | WO2000043521A2 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 07/27/2000 | WO2000043520A2 Materials and methods for producing geminivirus resistant plants |
| 07/27/2000 | WO2000043519A2 Neisseria meningitidis polypeptides |
| 07/27/2000 | WO2000043518A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | WO2000043517A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | WO2000043516A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | WO2000043515A2 Methods of monitoring hiv drug resistance |
| 07/27/2000 | WO2000043514A2 Human acid sensing ion channel and uses thereof |
| 07/27/2000 | WO2000043513A1 17723 receptor, a g-protein coupled receptor |
| 07/27/2000 | WO2000043512A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043510A2 Ras activator nucleic acid molecules - guanine nucleotide releasing factor grf4, polypeptides and methods of use |
| 07/27/2000 | WO2000043509A2 Polynucleotides and their applications in diagnostics |
| 07/27/2000 | WO2000043507A1 Method for producing antibody fragments |
| 07/27/2000 | WO2000043503A1 Improved phytases |
| 07/27/2000 | WO2000043501A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert) |
| 07/27/2000 | WO2000043498A2 Human liver progenitors |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043493A2 Metalloproteinase adam 22 |
| 07/27/2000 | WO2000043492A2 Method of site specific labeling of proteins and uses therefor |
| 07/27/2000 | WO2000043490A2 Rhamnosyl-transferase gene and uses thereof |
| 07/27/2000 | WO2000043420A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | WO2000043410A2 Novel odorant receptors in drosophila |
| 07/27/2000 | WO2000043409A2 Alpha-conotoxin peptides |
| 07/27/2000 | WO2000043044A1 Compositions and methods for controlled delivery of virus vectors |
| 07/27/2000 | WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | WO2000043030A1 Method of suppressing ongoing acute allograff rejection |
| 07/27/2000 | WO2000043029A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | WO2000043014A2 Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections |
| 07/27/2000 | WO2000042972A2 Compositions and methods for intraductal gene therapy |
| 07/27/2000 | WO2000042856A1 Activation of regulatory t cells by alpha-melanocyte stimulating hormone |
| 07/27/2000 | WO2000042855A1 Biological control of nematodes |
| 07/27/2000 | WO2000031281A3 Dna sequence encoding a glutamate/malate translocator, plasmids, bacteria, yeasts and plants containing said transporter |
| 07/27/2000 | WO2000031261A3 Methods and compositions for identifying effectors of the formyl peptide receptor like-1 (fprl-1) receptor |
| 07/27/2000 | WO2000028010A3 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 07/27/2000 | WO2000027883A3 A method of treating tumors using fas-induced apoptosis |
| 07/27/2000 | WO2000023618B1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 07/27/2000 | WO2000023597A3 Tissue-specific promoters for gene expression |
| 07/27/2000 | WO2000023593A3 Molecular pathogenicide mediated plant disease resistance |
| 07/27/2000 | WO2000023592A3 Minimal promoters and uses thereof |
| 07/27/2000 | WO2000023588A3 G-protein coupled receptors |
| 07/27/2000 | WO2000023567A3 Promotion of self-renewal and improved gene transduction of hematopoietic stem cells by histone deacetylase inhibitors |
| 07/27/2000 | WO2000023094A3 Methods of inhibiting platelet activation and recruitment |
| 07/27/2000 | WO2000022141A3 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 07/27/2000 | WO2000022001A8 A potassium channel of the erg family |
| 07/27/2000 | WO2000021553A3 Method of regulating smn gene expression |
| 07/27/2000 | WO2000018915A3 Membrane-associated organizational proteins |
| 07/27/2000 | WO2000018909A3 NUCLEIC ACIDS AND PROTEINS FROM $i(CENARCHAEUM SYMBIOSUM) |
| 07/27/2000 | WO2000017375A3 Method to treat haemophilia by in vivo gene therapy with retroviral vectors |
| 07/27/2000 | WO2000017319A3 Synthesis of vanillin from a carbon source |
| 07/27/2000 | WO2000014254A3 Component of bromelain |
| 07/27/2000 | WO2000011171A3 Human rna-associated proteins |
| 07/27/2000 | WO2000009712A8 Transcription factors regulating the expression of ethylene-inducible genes |
| 07/27/2000 | WO2000009699A9 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 07/27/2000 | WO2000009159A9 Compositions of cpg and saponin adjuvants and methods thereof |
| 07/27/2000 | WO2000007038A9 Protein fragment complementation assays |
| 07/27/2000 | WO2000006763A9 Fusion products containing insoluble proteinaceous tag |
| 07/27/2000 | WO2000005253A9 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 07/27/2000 | WO2000004157A3 Cloning and characterisation of novel mammalian peptidases |
| 07/27/2000 | WO2000002899A9 Method of using an improved peptide nucleic acid universal library to optimize dna sequence hybridation |
| 07/27/2000 | WO2000001829A9 Formaldehyde dehydrogenase genes from methylotrophic yeasts |
| 07/27/2000 | WO1999066302A9 Recognition of protein coding regions in genomic dna sequences |
| 07/27/2000 | WO1999058657A3 Zea mays phosphate transporter genes and uses thereof |
| 07/27/2000 | WO1999045116A9 Human homolog of a nuclear migration gene and its use |
| 07/27/2000 | DE19960271A1 Sarcosine oxidase, useful for diagnosing diseases such as nephropathy, hydrolyzes 1 mol sarcosine oxidatively |
| 07/27/2000 | DE19926457A1 Verfahren zur elektrochemischen Detektion von Nukleinsäure-Oligomer-Hybridisierungsereignissen A process for electrochemically detecting nucleic acid oligomer hybridization events |
| 07/27/2000 | DE19902550A1 A novel aspartate protease, coding sequence, inhibitors and antibodies, useful for treatment and diagnosis of Alzheimer's disease |
| 07/27/2000 | DE10003356A1 Novel ribozymes targeted against the catalytic subunit of the human telomerase enzyme reverse transcriptase are useful for treating tumors |
| 07/27/2000 | CA2575023A1 Raman optrode processes and devices for detection of chemicals and microorganisms |
| 07/27/2000 | CA2361272A1 33 human secreted proteins |
| 07/27/2000 | CA2361138A1 Alpha-conotoxin peptides |
| 07/27/2000 | CA2360748A1 Method and apparatus for the automated generation of nucleic acid ligands |
| 07/27/2000 | CA2360730A1 Human liver progenitors |
| 07/27/2000 | CA2360724A1 Mammalian serine racemase |
| 07/27/2000 | CA2360667A1 Neisseria meningitidis basb054 polypeptides and encoding polynucleotides and uses thereof |
| 07/27/2000 | CA2360658A1 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 07/27/2000 | CA2360609A1 Basb055 polynucleotide and polypeptide from neisseria meningitidis. uses thereof |
| 07/27/2000 | CA2360062A1 Baff, inhibitors thereof and their use in the modulation of b-cell response |
| 07/27/2000 | CA2360058A1 Uses of vascular endothelial growth factor in the treatment of erectile dysfunction |
| 07/27/2000 | CA2360027A1 Immobilization of molecules on surfaces via polymer brushes |
| 07/27/2000 | CA2359490A1 Biological control of nematodes |
| 07/27/2000 | CA2359145A1 Exocytosis pathway proteins and methods of use |
| 07/27/2000 | CA2358963A1 Cancer-associated proteins |
| 07/27/2000 | CA2358944A1 Selection procedure using prodrug/enzyme system |
| 07/27/2000 | CA2358930A1 Zsig67: a member of the human secretin-glucagon-vip hormone family |
| 07/27/2000 | CA2358926A1 Endogenetic nucleic fragment associated with an autoimmune disease, marking method and reagent |
| 07/27/2000 | CA2358914A1 Polypeptides derived from jnk3 |
| 07/27/2000 | CA2358899A1 Polypeptide |
| 07/27/2000 | CA2358873A1 Human polypeptide having multiple epidermal growth factor (egf) -like domains, zntr2 |
| 07/27/2000 | CA2358800A1 Reagents and methods useful for detecting diseases of the breast |
| 07/27/2000 | CA2358697A1 Polynucleotides and their applications in diagnostics |